Mark Barry Abelson

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA.

Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.